Biggest News Aggregation in the World
๐Ÿ“ฐ Michael Grey News

Page 2 - Michael Grey News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Michael Grey. Real-time updates on events, politics, business and more.

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Down to $30.09

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) gapped down prior to trading on Wednesday . The stock had previously closed at $30.09, but opened at $28.50. Mirum Pharmaceuticals shares last traded at $28.65, with a volume of 109,835 shares traded. Analyst Upgrades and Downgrades MIRM has been the topic of a number of research reports. […]
Christopher Peetz Niall Odonnel Raymond James Mirum Pharmaceuticals Mirum Pharmaceuticals Inc News Ratings For Mirum Pharmaceuticals Daily

NEA Management Company LLC Decreases Stock Holdings in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM)

NEA Management Company LLC reduced its position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) by 0.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,186,243 shares of the company’s stock after selling 1,558 shares during the quarter. Mirum Pharmaceuticals […]
Raymond James Niall Odonnel Christopher Peetz News Ratings For Mirum Pharmaceuticals Daily Nea Management Company Securities Exchange Commission
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Research Analysts Issue Forecasts for Mirum Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:MIRM)

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) – SVB Leerink issued their FY2025 earnings per share estimates for Mirum Pharmaceuticals in a research note issued to investors on Thursday, May 4th. SVB Leerink analyst M. Foroohar anticipates that the company will post earnings per share of $1.93 for the year. SVB Leerink has a “Outperform” […]
Niall Odonnel Raymond James Christopher Peetz Mirum Pharmaceuticals Company Profile Raymond James Associates Securities Exchange Commission

Insider Selling: Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Director Sells 14,608 Shares of Stock

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) Director Michael G. Grey sold 14,608 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were sold at an average price of $28.00, for a total value of $409,024.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, […]
Christopher Peetz Niall Odonnel Raymond James Mirum Pharmaceuticals Inc Eventide Asset Management Jacobs Levy Equity Management Inc

Mirum Pharmaceuticals (MIRM) to Release Earnings on Thursday

Mirum Pharmaceuticals (NASDAQ:MIRM – Get Rating) will be issuing its quarterly earnings data after the market closes on Thursday, May 4th. Analysts expect the company to announce earnings of ($0.96) per share for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link. Mirum Pharmaceuticals […]
Niall Odonnel Christopher Peetz Raymond James Earnings History For Mirum Pharmaceuticals Mirum Pharmaceuticals Vanguard Group Inc
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science